|
|
Vaccine Detail
|
HeV-sG-V |
| Vaccine Information |
- Vaccine Name: HeV-sG-V
- Target Pathogen: Nipah virus
- Target Disease: Nipah virus disease
- Type: Subunit vaccine
- Status: Licensed
- Host Species for Licensed Use: Human
- Antigen: HeV-sG recombinant antigen(Geisbert et al., 2021)
- Preparation: P1 stock was obtained from CDC, p2 stock was prepared in Vero E6 cells and stored at University of Texas Medical Branch (UTMB) on 30 May 2011. The virus is stored at −80 °C, tested negative for mycoplasma and endotoxin.(Geisbert et al., 2021)
- Immunization Route: Intramuscular injection (i.m.)
- Storage: The virus is stored at −80 °C
|
| Host Response |
|
|
| References |
|
|
|
